A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Clinical trial NCT06820463 · RECRUITING
Trial details
- NCT number
- NCT06820463
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2028-03-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.